Chronic simple lichen
Conditions
Interventions
Benvitimod cream group:NA
Desonide cream group:NA
Sponsors
Taizhou Central Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) It meets the diagnostic criteria of chronic simple lichen, and is suitable for patients treated with Benvitimod cream; (2) Age >= 18 years old, = 8 points, of which the target lesion lichen like change score was >= 2 points, and the target lesion pruritus score was >= 2 points; (5) Women who were not pregnant and did not plan pregnancy during the trial; (6) Fully understand the content of the trial treatment, voluntarily participate in the trial treatment and have signed the informed consent; (6) Voluntarily participated in this observational study and signed the informed consent.
Exclusion criteria
Exclusion criteria: (1) Pregnant women, lactating women, or women preparing for pregnancy; (2) Known allergy to the active ingredients or excipients of the study drug; (3) Skin lesions with obvious exudation or accompanied by bacterial and fungal infections; (4) The patient may not be able to complete this study for other reasons, or the investigator believes that it is not appropriate to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total skin lesion symptom score (TSS); | — |
Secondary
| Measure | Time frame |
|---|---|
| Eczema area and severity index,EASI;Dermatology quality of life index (DLQI); | — |
Countries
China
Contacts
Public ContactChen Jinguang
Taizhou Central Hospital
Outcome results
None listed